Companies × risks
Novonesis
Novonesis deploys AI/ML at scale for internal R&D, rolling out digital platforms (Benchling, Riffyn) across over 1,500 scientists. It also develops specialised ML methods for protein and enzyme design, training models on in-house experimental data for biosolutions applications.
We reviewed 1 public document from Novonesis and found it acknowledges none of the 24 AI risks we looked for.
Sector: Agriculture, Mining, Construction and Manufacturing; Chemicals & pharmaceutical manufacturing
Roles: AI deployer; Specialized AI developer
Documents we reviewed
- Novonesis Annual Report 2024 (Annual report, 2025)